Grant: Discovery Grants Program - Individual
Université Laval
$45,000.00
Model system for genetic and chemical probing of tertiary lymphoid organ formation
FY 2015-16
Summary
Lungs are exposed daily to dust and microbes. The immune system of the lung is efficient at responding to these stresses/threats to protect the host, but mechanisms explaining this efficiency are still misunderstood. A structure called inducible bronchus-associated lymphoid tissue was recently shown to enhance pulmonary defense against microbes, and to be sufficient for clearance of viruses targeting the airways (like viruses causing flu). In spite of the increasing importance of inducible bronchus-associated lymphoid tissue, the mechanisms involved in its formation are misunderstood. Sphingolipids (a class of endogenous signaling molecules) lately emerged as key regulators of the pulmonary immune system. Although, sphingolipids are likely determinants of inducible bronchus-associated lymphoid tissue formation, their contribution to this process is still unknown. The goal of this program is thus to define how sphingolipids regulate inducible bronchus-associated lymphoid tissue formation. We will characterize murine models of inducible bronchus-associated lymphoid tissue formation in response to microbes. Then, we will develop strategies to target cells involved in this process with various experimental agents. An array of genetic (invalidation of genes) and chemical strategies (molecules that inhibit or activate specific targets) will be combined to delineate how sphingolipids regulate the numerous steps of inducible bronchus-associated lymphoid tissue formation. Determining how inducible bronchus-associated lymphoid tissue develops will further our understanding of how the pulmonary immune system works. This program will also advance experimental strategies to study signaling lipids in the context of pulmonary immune defense. This program will result in the training of highly qualified personnel in the fields of immunology, lung biology and signaling lipids. Our results will be documented in specialized journals in the fields of small bioactive molecules and lung biology; as well as in broad interest journals with topics of regulation of immunity and cell biology.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
402151-2011
Name nom
Marsolais, David
Department département
Médecine
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2011
Award amount
45000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5204
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Immunology
Research subject fr
Immunologie
Partie
5
Nb partie
5
Application title
Model system for genetic and chemical probing of tertiary lymphoid organ formation
Keyword
NSERC
Application summary
Lungs are exposed daily to dust and microbes. The immune system of the lung is efficient at responding to these stresses/threats to protect the host, but mechanisms explaining this efficiency are still misunderstood. A structure called inducible bronchus-associated lymphoid tissue was recently shown to enhance pulmonary defense against microbes, and to be sufficient for clearance of viruses targeting the airways (like viruses causing flu). In spite of the increasing importance of inducible bronchus-associated lymphoid tissue, the mechanisms involved in its formation are misunderstood. Sphingolipids (a class of endogenous signaling molecules) lately emerged as key regulators of the pulmonary immune system. Although, sphingolipids are likely determinants of inducible bronchus-associated lymphoid tissue formation, their contribution to this process is still unknown. The goal of this program is thus to define how sphingolipids regulate inducible bronchus-associated lymphoid tissue formation. We will characterize murine models of inducible bronchus-associated lymphoid tissue formation in response to microbes. Then, we will develop strategies to target cells involved in this process with various experimental agents. An array of genetic (invalidation of genes) and chemical strategies (molecules that inhibit or activate specific targets) will be combined to delineate how sphingolipids regulate the numerous steps of inducible bronchus-associated lymphoid tissue formation. Determining how inducible bronchus-associated lymphoid tissue develops will further our understanding of how the pulmonary immune system works. This program will also advance experimental strategies to study signaling lipids in the context of pulmonary immune defense. This program will result in the training of highly qualified personnel in the fields of immunology, lung biology and signaling lipids. Our results will be documented in specialized journals in the fields of small bioactive molecules and lung biology; as well as in broad interest journals with topics of regulation of immunity and cell biology.